Skip to main content
Donate

Elizabeth Berry-Kravis, MD, PhD

I became involved in translational work in AS through the Ovid trials in 2017 and shortly thereafter initiated an Angelman Syndrome Clinic at Rush with Dr. Cesar Ochoa. Since that time we have tried to provide excellent clinical care and participate in many clinical trials and natural history studies in AS.
Elizabeth Berry-Kravis, MD, PhD headshot
Elizabeth Berry-Kravis, MD, PhD

Board Member

Professor of Pediatrics, Neurological Sciences, Anatomy and Cell Biology

Rush University Medical Center, Chicago, IL

Elizabeth Berry-Kravis MD, PhD is a Professor of Pediatrics and Neurological Sciences and Director of the RUSH Pediatric Neurosciences F.A.S.T. Center for Translational Research at Rush University Medical Center in Chicago. She established the Fragile X Clinic and Research Program at Rush University Medical Center in 1992 and has provided care to over 800 patients with fragile X syndrome (FXS). She conducts research on FXS, including genotype-phenotype, molecular, biomarker, outcome measure, and natural history studies, and clinical trials. She has expanded this clinical and translational work to other neurogenetic diseases in the past 10 years, including work on PMS, NPC, Angelman syndrome, Rett syndrome, Batten’s disease, PKAN, and creatine transport deficiency. She has led the effort to develop new targeted treatments for FXS and other genetic neurological diseases, and has implemented novel trial designs, including N-of-1 trials.

FAST Global Science Summit Presentations